AtaiBeckley is a pioneering force in the field of mental health, established in 2025 through the strategic merger of atai Life Sciences and Beckley Psytech. The organization is dedicated to creating innovative, rapid-acting mental health therapies that aim to improve outcomes for patients facing difficult-to-treat conditions. Grounded in rigorous scientific research, AtaiBeckley is committed to transforming the landscape of mental health treatment, fostering breakthroughs that bring new hope to individuals and communities.

The core values of AtaiBeckley are deeply rooted in purpose, resilience, and clarity. The team thrives on the ability to face challenges head-on, constantly seeking opportunities where others may see none. Their leadership team boasts extensive experience in biotech and pharmaceutical drug development, providing strategic insight that drives impactful mental health solutions. Focused on developing effective and accessible treatments, AtaiBeckley strives to make a significant difference in the lives of those dealing with mental health issues while also advocating for a brighter future in mental health care.